1.Detection of subarachnoid haemorrhage with gradient echo T_2 ~*sequences
Chinese Journal of Neurology 2000;0(05):-
Objective To measure the sensitivity and specificity of gradient echo T*_2(GRE-T*_2) to subarachnoid haemorrhage (SAH). Methods 12 patients with SAH underwent MRI using T_1WI, T_2WI, FLAIR, GRE-T*_2 sequences and CT as well. Results (1)In the acute-stage of the patients, SAH was seen as an area of high signal intensity as compared with the surrounding cerebrospinal fluid in 66.6% of the cases on T_1-weighted images, and in 100% on FLAIR images; low signal intensities were seen in 50.0% of the cases on T_2-weighted images, and in 100% on GRE-T*_2-weighted images; (2) In the subacute of the patients, SAH was detected on T_1-weighted images (25.0% of cases), FLAIR (25.0%), T_2-weighted images (0), GRE-T*_2-weighted images (100.0%); (3) In the patients with atypical SAH, both CT and FLAIR sequence in MRI were negative for SAH, while lumber acupuncture and GRE-T*_2 had positive findings. Conclusion GRE-T*_2 is the most sensitive sequence of MRI for detecting acute and subacute SAH and has significant advantages over CT in the detection of subacute and atypical SAH.
2.Research advances in hepatic echinococcosis with cavernous transformation of the portal vein
Journal of Clinical Hepatology 2021;37(4):965-968
Compression by hepatic hydatid lesions may invade the portal vein and cause cavernous transformation of the portal vein (CTPV), which has difficulties and high risks in surgery, and conventional hepatectomy cannot achieve radical treatment. This article reviews the etiology, classification, clinical manifestations, and auxiliary examinations of hepatic echinococcosis with CTPV and summarizes the treatment strategies for this disease. It is believed that the treatment of hepatic echinococcosis with CTPV should combine the resection of hydatid lesions with the effective relief of portal hypertension, and revascularization and ex-vivo liver resection with auto-transplantation play an important role in radical resection.
3.Hepatectomy for hepatic alveolar echinococcosis complicating cavernous transformation of the portal vein
Maolin WANG ; Bo RAN ; Tiemin JIANG ; Ruiqing ZHANG ; Qiang GUO ; Hao WEN ; Yingmei SHAO
Chinese Journal of General Surgery 2021;36(8):595-599
Objective:To investigate the safety and feasibility of hepatectomy in the treatment of hepatic alveolar echinococcosis with secondary cavernous transformation of the portal vein.Methods:The clinical data of 7 patients undergoing surgery at the First Affiliated Hospital of Xinjiang Medical University from Jan 2010 to Dec 2019 were retrospectively analyzed.Results:There were 1 case of cavernous type Ⅰ transformation of the portal vein and 6 cases of type Ⅱ. All patients underwent partial hepatectomy. The average operation time was (9.24±4.09) h. Two patients underwent resection of cavernous segment of portal vein and reconstruction by graft, Albendazole was taken orally for 2 years after discharge. Anticoagulants were taken orally in patients with artificial vascular reconstruction. No recurrence and vascular complications were found. Five patients underwent palliative resection without resection of the cavernous segment of the portal vein. During the follow-up, cavernous transformation of the portal vein progressed in 3 patients, 2 of them esophageal varices rupture and bleeding.Conclusion:Radical hepatectomy and revascularization are the first choice for the treatment of hepatic alveolar echinococcosis complicated with secondary cavernous transformation of portal vein the result was fair.
4.Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332.
Yao ZHAO ; Chao FANG ; Qi ZHANG ; Ruxue ZHANG ; Xiangbo ZHAO ; Yinkai DUAN ; Haofeng WANG ; Yan ZHU ; Lu FENG ; Jinyi ZHAO ; Maolin SHAO ; Xiuna YANG ; Leike ZHANG ; Chao PENG ; Kailin YANG ; Dawei MA ; Zihe RAO ; Haitao YANG
Protein & Cell 2022;13(9):689-693